Scarica l'app Stockscreener
3.95
22.55%
-1.15
Dopo l'orario di chiusura:
3.67
-0.28
-7.09%
Precedente Chiudi:
$5.10
Aprire:
$4.12
Volume 24 ore:
157.89K
Relative Volume:
2.79
Capitalizzazione di mercato:
$18.65M
Reddito:
-
Utile/perdita netta:
$-20.70M
Rapporto P/E:
-0.000595
EPS:
-6633.8863
Flusso di cassa netto:
$-15.13M
1 W Prestazione:
-59.78%
1M Prestazione:
-75.82%
6M Prestazione:
-97.09%
1 anno Prestazione:
-99.82%
Intervallo 1D:
$3.83
$4.59
Intervallo di 1 settimana:
$3.83
$11.00
Portata 52W:
$3.83
$4,200.00
Cdt Equity Inc Stock (CDT) Company Profile
Nome
Cdt Equity Inc
Settore
Industria
Telefono
(646) 491 9132
Indirizzo
4851 TAMIAMI TRAIL NORTH, NAPLES
Compare CDT vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CDT
Cdt Equity Inc
|
3.95 | 18.65M | 0 | -20.70M | -15.13M | -6,633.89 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Cdt Equity Inc Borsa (CDT) Ultime notizie
CDT PE Ratio & Valuation, Is CDT Overvalued - Intellectia AI
12 Health Care Stocks Moving In Thursday's After-Market SessionBullfrog AI Hldgs (NASDAQ:BFRG), CDT Eq - Benzinga
CDT (NASDAQ: CDT) expands at‑the‑market capacity to $76.1M under AGP pact - Stock Titan
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Morning Market Movers: ELAB, BATL, CSHR, CDT See Big Swings - RTTNews
CDT Equity Delays Annual Report Filing - TipRanks
CDT Equity files for non-timely 10-K with US SEC - marketscreener.com
CDT Equity Files For Non-Timely 10-K With US SEC - TradingView
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
CDT Surges 32% on New Patents, But Will It Hold Above $6? - Bitget
CDT Equity (CDT) notifies late 10-K; expects filing within 15 days - Stock Titan
Morning Market Movers: APLS, PEPG, CDT, PHR See Big Swings - RTTNews
Discover the top movers in Tuesday's pre-market session. - ChartMill
CDT Equity (CDT) entities cashlessly exercise all pre-funded warrants - Stock Titan
CDT Equity (CDT) discloses pre-funded warrants from Sarborg deal - Stock Titan
Mark Taylor Discloses Investment in CDT Equity Inc. with 43.79% Stake - TradingView
Sarborg deal leaves CDT Equity (CDT) with investor group owning 43.79% of shares - Stock Titan
CDT Crashes 24% in Intraday Trading Amid Patent Filing and Market Doldrums — What’s Next? - Bitget
CDT Equity announces reverse stock split - MSN
CDT Equity files patents for tapinarof combination therapy By Investing.com - Investing.com South Africa
CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings - Bitget
CDT Equity files patents for tapinarof combination therapy - Investing.com
CDT Equity Announces 1-for-25 Reverse Stock Split - The Globe and Mail
CDT Equity approves 1-for-25 reverse stock split effective Thursday - Investing.com Australia
Conduit to change name to CDT Equity - MSN
Cdt Equity Inc. announces reverse stock split - MarketScreener
Cdt Equity Inc. Announces Reverse Stock Split - TradingView
Reverse split shrinks CDT Equity (NASDAQ: CDT) share count 25-to-1 - Stock Titan
CDT Equity Inc. Announces Reverse Stock Split - bitget.com
Cdt identifies rare disease opportunities through Sarborg Signature Analysis, advancing out-licensing strategy - marketscreener.com
CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy - The Manila Times
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
If You Invested $1,000 in CDT Equity (CDT) - Stock Titan
AI scan links CDT assets to rare diseases with few treatment options - Stock Titan
CDT Equity Inc. 8-K Filing March 17, 2026: Company Details, Address, Trading Symbol, and Emerging Growth Status - Minichart
CDT Equity Shareholders Approve Major Capital Restructuring Measures - TipRanks
CDT Equity (NASDAQ: CDT) wins backing for large share issues and Cayman move - Stock Titan
Latest CDT NewsConduit Pharmaceuticals to Present at the Op... - Stock Titan
CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth - Bitget
Cdt Equity stockholders approve all proposals at special meeting, positioning the company for next phase of growth - marketscreener.com
Cdt Equity Stockholders Approve All Proposals At Special Meeting, Positioning The Company For Next Phase Of Growth - TradingView
CDT Equity to map asset portfolio against rare disease database By Investing.com - Investing.com India
CDT Equity to map asset portfolio against rare disease database - Investing.com South Africa
CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence - The Manila Times
CDT Stock Price, Quote & Chart | CDT EQUITY INC (NASDAQ:CDT) - ChartMill
CDT Equity Expands Financing Through New Convertible Note - The Globe and Mail
Cdt Equity lowers floor price to $0.60 in purchase agreement amendment on March 3, 2026SEC filing - marketscreener.com
Cdt Equity Inc Azioni (CDT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):